2
4
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Vitiligo on the face
Vitiligo on the face
Tuberous sclerosis, hypopigmented macule
Tuberous sclerosis, hypopigmented macule
Vitiligo on the back and arm
Vitiligo on the back and arm

Vitiligo
Definition:
Vitiligo is a skin condition in which there is loss of pigment from areas of skin resulting in irregular white patches with normal skin texture.

Causes, incidence, and risk factors:

Vitiligo appears to be an acquired condition and may appear at any age. There is an increased incidence in some families. Vitiligo is more noticeable in darker skinned people because of the contrast.

The cause of vitiligo is unknown, but autoimmunity may be a factor. This condition affects about 1% of the U.S. population.

Lesions appear as flat depigmented areas with a darker boarder. The edges are sharply defined but irregular. Frequently affected areas are the face, elbows and knees, hands and feet, and genitalia.
Symptoms:
  • Family history of vitiligo
  • Sudden or gradual onset of flat normally textured areas of skin with complete pigment loss
Signs and tests:
Examination is usually sufficient to confirm the diagnosis. In some cases, a skin biopsy may be needed to rule out other causes of pigment loss.
Treatment:

Vitiligo is difficult to treat. Early treatment options include the following:

  • Exposure to intense ultraviolet light, such as narrow-band UVB therapy
  • Oral medications, such as Trisoralen (trimethylpsoralen)
  • Topical medications
    • Repigmenting agents such as Oxsoralen (methoxsalen)
    • Immunosuppressants such as Elidel (pimecrolimus) and Protopic (tacrolimus)
    • Corticosteroid creams

Skin may be grafted, or removed from normal areas and placed into areas of pigment loss. In the future, skin pigment cells may be grown in the laboratory and used to treat areas of vitiligo.
Support Groups:
  • VitiligoSupport.com, http://www.vitiligosupport.com/www.vitiligosupport.com
  • American Vitiligo Research Foundation,http://www.avrf.org/www.avrf.org
  • National Vitiligo Foundation, http://www.nvfi.org/www.nvfi.org
Expectations (prognosis):
The course of vitiligo varies. Some areas may repigment, but other new areas may appear. Depigmentation may be progressive.
Complications:
Depigmented areas are more likely to sunburn or develop certain skin cancers. Vitiligo is associated with three systemic diseases: 1) pernicious anemia, 2) hyperthyroidism, and 3) Addison's disease.
Calling your health care provider:
Call for an appointment with your health care provider if you develop areas of skin that lose their coloring.
Review Date: 8/26/2002
Reviewed By: A.D.A.M. editorial. Previous review: Michael Lehrer, M.D., Department of Dermatology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network (7/28/2001).
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com